12-53424398-C-T
Variant summary
Our verdict is Uncertain significance. The variant received 4 ACMG points: 4P and 0B. PS1_ModeratePP5_Moderate
The NM_020547.3(AMHR2):c.160C>T(p.Arg54Cys) variant causes a missense change. The variant allele was found at a frequency of 0.000018 in 1,613,622 control chromosomes in the GnomAD database, including 1 homozygotes. Variant has been reported in ClinVar as Likely pathogenic (★). Another nucleotide change resulting in the same amino acid substitution has been previously reported as Likely pathogenic in UniProt. Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R54H) has been classified as Uncertain significance.
Frequency
Consequence
NM_020547.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 4 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
AMHR2 | ENST00000257863.9 | c.160C>T | p.Arg54Cys | missense_variant | Exon 2 of 11 | 1 | NM_020547.3 | ENSP00000257863.3 | ||
AMHR2 | ENST00000379791.7 | c.160C>T | p.Arg54Cys | missense_variant | Exon 2 of 9 | 1 | ENSP00000369117.3 | |||
AMHR2 | ENST00000550311.5 | c.160C>T | p.Arg54Cys | missense_variant | Exon 2 of 11 | 1 | ENSP00000446661.1 | |||
AMHR2 | ENST00000553037.1 | n.121C>T | non_coding_transcript_exon_variant | Exon 1 of 2 | 4 |
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152150Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000639 AC: 16AN: 250270 AF XY: 0.0000960 show subpopulations
GnomAD4 exome AF: 0.0000185 AC: 27AN: 1461354Hom.: 1 Cov.: 32 AF XY: 0.0000261 AC XY: 19AN XY: 726980 show subpopulations
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152268Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74452 show subpopulations
ClinVar
Submissions by phenotype
Persistent Mullerian duct syndrome Pathogenic:1
Variant summary: AMHR2 c.160C>T (p.Arg54Cys) results in a non-conservative amino acid change in the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 6.4e-05 in 250270 control chromosomes in the gnomAD database, including 1 homozygotes. This frequency is not significantly higher than estimated for a pathogenic variant in AMHR2 causing Persistent Mullerian duct syndrome, allowing no conclusion about variant significance. c.160C>T has been reported in the literature in the compound heterozygous state in at least 2 individuals affected with Persistent Mullerian duct syndrome (example, Imbeaud_1996, Tian_2022), including at least 1 individual carrying a pathogenic variant in trans. These data indicate that the variant may be associated with disease. At least one publication reports experimental evidence evaluating an impact on protein function. In vitro experiments showed this variant prevented binding of the ligand protein (encoded by AMH) and also eliminated the activation of a target gene by AMH, suggesting the activation pathway is disrupted by this variant (example, Belville_2009). The following publications have been ascertained in the context of this evaluation (PMID: 19457927, 8872466, 34810374). No submitters have cited clinical-significance assessments for this variant to ClinVar. Based on the evidence outlined above, the variant was classified as likely pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at